243 related articles for article (PubMed ID: 23592239)
1. Model predicting impact of complexation with cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2013 Sep; 110(9):2536-47. PubMed ID: 23592239
[TBL] [Abstract][Full Text] [Related]
2. Modeling the influence of cyclodextrins on oral absorption of low-solubility drugs: I. Model development.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):409-20. PubMed ID: 19725042
[TBL] [Abstract][Full Text] [Related]
3. Drug salts and solubilization: modeling the influence of cyclodextrins on oral absorption.
Gamsiz ED; Thombre AG; Ahmed I; Carrier RL
Ann Biomed Eng; 2011 Jan; 39(1):455-68. PubMed ID: 20960062
[TBL] [Abstract][Full Text] [Related]
4. Modeling the influence of cyclodextrins on oral absorption of low solubility drugs: II. Experimental validation.
Gamsiz ED; Miller L; Thombre AG; Ahmed I; Carrier RL
Biotechnol Bioeng; 2010 Feb; 105(2):421-30. PubMed ID: 19725043
[TBL] [Abstract][Full Text] [Related]
5. The utility of cyclodextrins for enhancing oral bioavailability.
Carrier RL; Miller LA; Ahmed I
J Control Release; 2007 Nov; 123(2):78-99. PubMed ID: 17888540
[TBL] [Abstract][Full Text] [Related]
6. Development of a new delivery system consisting in "drug--in cyclodextrin--in nanostructured lipid carriers" for ketoprofen topical delivery.
Cirri M; Bragagni M; Mennini N; Mura P
Eur J Pharm Biopharm; 2012 Jan; 80(1):46-53. PubMed ID: 21839833
[TBL] [Abstract][Full Text] [Related]
7. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
8. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
9. Cyclodextrin-poly(anhydride) nanoparticles as new vehicles for oral drug delivery.
Agüeros M; Espuelas S; Esparza I; Calleja P; Peñuelas I; Ponchel G; Irache JM
Expert Opin Drug Deliv; 2011 Jun; 8(6):721-34. PubMed ID: 21463219
[TBL] [Abstract][Full Text] [Related]
10. Cyclodextrins: Efficient biocompatible solubilizing excipients for bromhexine liquid and semi-solid drug delivery systems.
Stojanov M; Nielsen HM; Larsen KL
Int J Pharm; 2012 Jan; 422(1-2):349-55. PubMed ID: 22027391
[TBL] [Abstract][Full Text] [Related]
11. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.
Beig A; Miller JM; Dahan A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1293-9. PubMed ID: 23770429
[TBL] [Abstract][Full Text] [Related]
12. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
[TBL] [Abstract][Full Text] [Related]
13. In-vitro prediction of bioavailability following extravascular injection of poorly soluble drugs: an insight into clinical failure and the role of delivery systems.
Wu Z; Hassan D; Shaw JP
J Pharm Pharmacol; 2013 Oct; 65(10):1429-39. PubMed ID: 24028610
[TBL] [Abstract][Full Text] [Related]
14. Cyclodextrins.
Stella VJ; He Q
Toxicol Pathol; 2008 Jan; 36(1):30-42. PubMed ID: 18337219
[TBL] [Abstract][Full Text] [Related]
15. Complexation of tanshinone IIA with 2-hydroxypropyl-beta-cyclodextrin: effect on aqueous solubility, dissolution rate, and intestinal absorption behavior in rats.
Wang L; Jiang X; Xu W; Li C
Int J Pharm; 2007 Aug; 341(1-2):58-67. PubMed ID: 17482783
[TBL] [Abstract][Full Text] [Related]
16. Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.
Chen X; Sun X; Ren K; Zhang X; Zhang Z; Gong T
Arzneimittelforschung; 2010; 60(9):571-4. PubMed ID: 21117501
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrins and chitosan derivatives in sublingual delivery of low solubility peptides: A study using cyclosporin A, alpha-cyclodextrin and quaternary chitosan N-betainate.
Mannila J; Järvinen K; Holappa J; Matilainen L; Auriola S; Jarho P
Int J Pharm; 2009 Oct; 381(1):19-24. PubMed ID: 19632311
[TBL] [Abstract][Full Text] [Related]
18. Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus.
Arima H; Yunomae K; Hirayama F; Uekama K
J Pharmacol Exp Ther; 2001 May; 297(2):547-55. PubMed ID: 11303042
[TBL] [Abstract][Full Text] [Related]
19. Toward Successful Cyclodextrin Based Solubility-Enabling Formulations for Oral Delivery of Lipophilic Drugs: Solubility-Permeability Trade-Off, Biorelevant Dissolution, and the Unstirred Water Layer.
Fine-Shamir N; Beig A; Zur M; Lindley D; Miller JM; Dahan A
Mol Pharm; 2017 Jun; 14(6):2138-2146. PubMed ID: 28505451
[TBL] [Abstract][Full Text] [Related]
20. Improvement of some pharmaceutical properties of drugs by cyclodextrin complexation. 5. Theophylline.
Ammar HO; Ghorab M; El-nahhas SA; Omar SM; Ghorab MM
Pharmazie; 1996 Jan; 51(1):42-6. PubMed ID: 8999434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
